助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   persisting hepatitis 的翻译结果: 查询用时:0.01秒
图标索引 在分类学科中查询
所有学科
中医学
临床医学
更多类别查询

图标索引 历史查询
 

persisting hepatitis
相关语句
  迁延性肝炎
     Anti-HBc-IgM serum tests were completed for 268 patients with chronic hepatitis B among whom 118 (77.6%) seropositive persons of 152 patients with chronic active hepatitis (CAH), 65(56%) seropositive persons of 116 patients with chronic persisting hepatitis (CPH) were identified respectively.
     对268例慢性乙型肝炎患者血清抗-HBc-IgM检测结果,慢性活动性肝炎152例,阳性118例,阳性率77.6%; 慢性迁延性肝炎116例,阳性65例,阳性率56.0%。
短句来源
     The results showed that the positive rates of IgM anti HCV Ab 2 in the patients with acute hepatitis C,chronic persisting hepatitis C,chronic active hepatitis C and hepatocirrhosis were 0%(0/17),38.1%(8/21),43.8%(14/32) and 36.4%(4/11) respectively.
     丙肝组内频率为急肝0%(0/17),慢性迁延性肝炎38.1%(8/21),慢性活动性肝炎43.8%(14/32),肝炎肝硬化36.4%(4/11)。 本法重复性好,批内变异系数4.6%,批间变异系数8.5%。
短句来源
     The authors observed 126 patients with chronic active hepatitis. There were 21 patients with chronic persisting hepatitis and 6 with chronic HBsAg carrier who were administrated with antiviral treatment. The results demonstrated that five factors affecting the anti-virus treatment as follows: ①the treatmental effect was bad in the patients who have family aggregation of HBV infection;
     对接受干扰素(IFNa)和阿糖腺苷抗病毒治疗的慢性活动性肝炎(CAH)126例,慢性迁延性肝炎(慢迁肝)21例和慢性HBV携带者6例进行分析,认为影响抗病毒疗效的主要因素有:①家庭HBV感染呈聚集性的病人疗效差;
短句来源
     The total effective rate in the treatment group for chronic persisting hepatitis and chronic active hepatitis were 89. 5% and 83. 9% respectively; while they were 69. 2% and 50% respectively in the control group.
     计算总有效率,慢性迁延性肝炎、慢性活动性肝炎观察组分别为89.5%、83.9%,对照组分别是69.2%、50%。
短句来源
     Except chronic persisting hepatitis,the other values of αFU were significantly higher than those of normal subjects(P<005).
     慢性迁延性肝炎与正常对照组无统计学差异(P>005)。
短句来源
  迁肝炎
     the value in acute hepatitis was 56~410,chronic persisting hepatitis 12~17,chronic active hepatitis 18~90,cirrhosis with ascites 18~50,cirrhosis without ascites 12~30,primary hepatocarcinoma 11~64,secondary hepatocarcinoma 16~95,and hepatic abscess 15~21 u/L.
     急性肝炎56~410、慢迁肝炎12~17、慢活肝炎18~90、有腹水肝硬化18~50、无腹水肝硬化12~30、原发性肝癌11~64、继发性肝癌16~95、肝脓肿15~21 u/L。
短句来源
  “persisting hepatitis”译为未确定词的双语例句
     The results of needle biopsy of liver for 60 cases of virus hepatitis showed that the accordance rate of clinical and pathological diagnosis was 46.6%in which the diagnostic accordance rate of acute hepatitis was the lowest(23.8%),and of chronic persisting hepatitis,44.8%;
     对60例病毒性肝炎患者进行肝穿刺活检,结果发现,临床与病理诊断的符合率为46.6%,其中,急性肝炎的诊断符合率最低(23.8%),慢性迁延型肝炎(慢迁肝)为44.8%;
短句来源
     612 patients with chronic liver diseases,including chronic persisting hepatitis,chronic active hepatitis, posthepatitic cirrhosis, schistosomiasis japonica were detected by the methods of serodiagnosis which are ADA, CG, β2-M, NAG, GST, HYP, PⅢP, HA, LN, TNF-α and sIL-2R,The results of serological test were indicated by positive rate(>X+2SD) and same as the results of hepatic histological examination.
     对慢迁肝、慢活肝、肝炎后肝硬化、日本血吸虫病早期和晚期患者共612例(其中157例经肝活检确诊)进行血清ADA、CG、β_2-M、NAG、GST、HyP、PIP、HA、LN、TNF-α、sIL-2R等11项指标的检测. 检测结果用阳性(>(?)
短句来源
     ). Peak IL-2 activity was seen on day 6 following ABS administration. The elevated percentage of T 4 lymphocytes and T 4/T 8 ratio were seen in the peripheral blood of the patients with chronic persisting hepatitis receiving ABS 4-8mg per day.
     给慢性迁延型肝炎患者肌肉注射ABS(4~8mg/日)后,看到其外周血T_4淋巴细胞百分比及T_4/T_8比例得以提高。
短句来源
     prolonged prothrombin time,A/G value<1. 2 and positive anti HBcIgM may be considerd as the important indexes for the differential diagnosis of chronic active hepatitis and chronic persisting hepatitis The above mentioned data are significant for elevating the accuracy of clinical typing diagnosis for virus hepatitis and guiding the clinical treatment.
     肝炎患者中脾肿大,凝血酶元时间延长、A/G值<1.2、抗HBcIgM阳性可作为慢活肝与慢迁肝鉴别的重要指标。 这些对提高病毒性肝炎临床分型诊断的准确率及指导临床治疗有意义。
短句来源
     Through studies separating from serums of positive and negative HBsAg, it is considered anti HBe-IgM might rise diagnosis level of HB. Comparing between serums of 1:400 diluted and non-diluted in acute hepatitis, persisting hepatitis and HBV carriers, it is found after serums diluted the difference of values of detection between every two groups in three groups was statistically significant (P<0.001).
     另外对急乙、慢迁及携带者三类患者血清进行1:400稀释与原血清检测比较,发现血清稀释后三组测值两两比较有高度显著差异(P<0.001)。
短句来源
更多       
查询“persisting hepatitis”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
没有找到相关例句


Passing the detection of anti HBc-IgM in different dilutions of serum, it's clinical significance is discussed. Using SPRIA method, nondiluted 254 specimens are detected. Through studies separating from serums of positive and negative HBsAg, it is considered anti HBe-IgM might rise diagnosis level of HB. Comparing between serums of 1:400 diluted and non-diluted in acute hepatitis, persisting hepatitis and HBV carriers, it is found after serums diluted the difference of values of detection between every...

Passing the detection of anti HBc-IgM in different dilutions of serum, it's clinical significance is discussed. Using SPRIA method, nondiluted 254 specimens are detected. Through studies separating from serums of positive and negative HBsAg, it is considered anti HBe-IgM might rise diagnosis level of HB. Comparing between serums of 1:400 diluted and non-diluted in acute hepatitis, persisting hepatitis and HBV carriers, it is found after serums diluted the difference of values of detection between every two groups in three groups was statistically significant (P<0.001). The result suggested that it is important and necessary to detect some dilutions in serums besides non-diluted.

本文通过血清不同稀释度抗HBc-IgM的检测,探讨了这一指标的临床意义。利用SPRIA法对245份血清进行原血清检测,分别对HBsAg阳性及阴性进行研究,抗HBc-IgM可以提高乙肝的诊断水平。另外对急乙、慢迁及携带者三类患者血清进行1:400稀释与原血清检测比较,发现血清稀释后三组测值两两比较有高度显著差异(P<0.001)。结果说明标本除原血清检测外,再做某些稀释度检测是非常重要和必要的。

Actinidia chinensis polysaccharide is a biologic response modifier. In view of its broad spectrum of immunological activity, the modulat ting ability of which to the immune responses of T lymphocyte was evaluated. The results showed that its preparation, Anbenshi (ABS), stimulated the proliferation of murine splenic lymphocytes and particul arly it enhanced the proliferation of murine thymocytes with a dosedependent manner and its optimal concentration was found to be 50μg /ml in vitro. Further studies showed...

Actinidia chinensis polysaccharide is a biologic response modifier. In view of its broad spectrum of immunological activity, the modulat ting ability of which to the immune responses of T lymphocyte was evaluated. The results showed that its preparation, Anbenshi (ABS), stimulated the proliferation of murine splenic lymphocytes and particul arly it enhanced the proliferation of murine thymocytes with a dosedependent manner and its optimal concentration was found to be 50μg /ml in vitro. Further studies showed that IL-2 secretion of splenic (?)ymphocytes was enhanced by post-inject ion of ABS(6mg & 24mg/kg, (?). p.). Peak IL-2 activity was seen on day 6 following ABS administration. The elevated percentage of T 4 lymphocytes and T 4/T 8 ratio were seen in the peripheral blood of the patients with chronic persisting hepatitis receiving ABS 4-8mg per day. The results suggested that the immune modulating effects of ABS could be related to (?)ts ability to induce T 4 lymphocytes to produce IL-2.

中华猕猴桃多糖是一种生物反应调节剂。本文研究了它的制剂(ABS)对T淋巴细胞的调节功效。ABS在体外用~3H-TdR掺入法证明能刺激小鼠脾淋巴细胞,特别是胸腺细胞的增殖,呈倒钟罩型剂量依赖关系曲线。最适浓度为50μg/ml。进一步研究显示,腹腔给予剂量为6mg及24mg/kg后能增进小鼠脾淋巴细胞分泌白细胞介素2(IL-2),其中6ma/kg剂量组脾细胞IL-2活性比对照组提高265%,高峰在停药后第6天。给慢性迁延型肝炎患者肌肉注射ABS(4~8mg/日)后,看到其外周血T_4淋巴细胞百分比及T_4/T_8比例得以提高。本文研究提示ABS的免疫调节作用与诱导T_4淋巴细胞並产生IL-2有关。

The authors observed 126 patients with chronic active hepatitis. There were 21 patients with chronic persisting hepatitis and 6 with chronic HBsAg carrier who were administrated with antiviral treatment. The results demonstrated that five factors affecting the anti-virus treatment as follows: ①the treatmental effect was bad in the patients who have family aggregation of HBV infection; ②the better treatmental effect was obtained in patients whose virus infection period was between six moths and two years,...

The authors observed 126 patients with chronic active hepatitis. There were 21 patients with chronic persisting hepatitis and 6 with chronic HBsAg carrier who were administrated with antiviral treatment. The results demonstrated that five factors affecting the anti-virus treatment as follows: ①the treatmental effect was bad in the patients who have family aggregation of HBV infection; ②the better treatmental effect was obtained in patients whose virus infection period was between six moths and two years, which the replication of virus was active; ③the better effect was observed in patients with higher transaminoase of serum; ④the bad effect showed in patients with chronic persisting hepatitis and HBsAg carrier; ⑤the effect of the combined administration of two anti-virus drugs is better than each one; the effect of two treatment courses or more is better than one. The age of patients doesn't effect the treatment significantly.

对接受干扰素(IFNa)和阿糖腺苷抗病毒治疗的慢性活动性肝炎(CAH)126例,慢性迁延性肝炎(慢迁肝)21例和慢性HBV携带者6例进行分析,认为影响抗病毒疗效的主要因素有:①家庭HBV感染呈聚集性的病人疗效差;②HBV感染时间长的病人疗效差,感染在6月至24月内且有病毒活跃复制者效果好,感染超过6年者效果差;③血清转氨酶水平较高者效果好;④慢迁肝和慢性HBV携带者的效果差;⑤两种抗病毒药联合应用优干单用;间歇两疗程以上优于单疗程。病人年龄不是影响疗效的主要因素。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关persisting hepatitis的内容
在知识搜索中查有关persisting hepatitis的内容
在数字搜索中查有关persisting hepatitis的内容
在概念知识元中查有关persisting hepatitis的内容
在学术趋势中查有关persisting hepatitis的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社